Taifour et al., sheds light on the mechanism that limits CD8+ T cell function in stromal tissue and proposes that targeting Chi3l1 may enhance anti-tumor immunity across numerous types of tumors [177]. The gene discussed is CHI3L1; the disease is neoplasm.